The June 10, 2024 list included 21 active substances.
The creation of the list, is the first stage of the reimbursement process. The prepared list will become the basis for further work on the reimbursement of drug technologies included in the list.
The next step is for the Minister of Health to create a list of drugs on the basis of the list, after consulting with the Transparency Council, national consultants in the relevant medical field and the Patient Ombudsman.
Subsequently, the Minister of Health informs the responsible entities whose drugs are on this list of the possibility of submitting an application for reimbursement coverage, as referred to in Article 24(1)(1) of the...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
